JOHN KIRKWOOD to Chronic Disease
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Chronic Disease.
Connection Strength
0.047
-
Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy. J Clin Oncol. 2002 Sep 01; 20(17):3703-18.
Score: 0.037
-
Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group. Cancer. 2003 Jul 01; 98(1):100-9.
Score: 0.010